Search results for: 'research area cell cycle rad51'
- F1557 Anti-CEACAM5/CEA/CD66e Antibody (Labetuzumab govitecan)Summary: Anti-CEACAM5/CEA/CD66e Antibody (Labetuzumab govitecan)
- K4413 Concanavalin A (Con A)-FITCSummary: FITC-Concanavalin A (ConA) Conjugate
- A8637 IOWH-032Target: CFTRSummary: CFTR inhibitor
- A2173 SC 1441 CitationTarget: GlycoproteinsSummary: Gp130 inhibitor
- B5629 TAS 301Summary: inhibitor of smooth muscle cell migration and proliferation, inhibits PKC signaling
- P1024 IL-7, human recombinantSummary: IL-7, lymphoid cell growth factor, expressed in E.Coli, cross-species reactive.
- C3095 N-OxalylglycineSummary: cell permeable inhibitor of α-ketoglutarate-dependent enzymes, including JMJD2A, JMJD2C, and JMJD2E.
- BA1208 DCAPSummary: DCAP is a broad-spectrum antibiotic that targets the cell membranes of Gram-positive and Gram-negative bacteria.
- BA1893 TucaresolSummary: Tucaresol is an orally bioavailable immune-enhancing drug that enhances T helper cell activity.
- BA3357 PZ703bSummary: PZ703b is a degradative agent that induces apoptosis and inhibits cancer cell proliferation.